<DOC>
	<DOCNO>NCT00878462</DOCNO>
	<brief_summary>This trial randomize trial determine patient 's acceptability unflavored antipsychotic medication compare raspberry flavor antipsychotic medication . Patients receive 6 total dos study drug ( 2 dos asenapine formulation ) 3 consecutive day : 2 different formulation day , 1 morning 1 evening . The formulation : white unflavored , white raspberry flavor , red raspberry flavor . Patients give questionnaire follow dose study medication ( one questionnaire twice per day 3 day ) measure acceptable formulation .</brief_summary>
	<brief_title>An Acceptability Study Unflavored Asenapine Versus Raspberry Flavored Asenapine Stable Patients With Psychotic Disorder ( P07010 ) ( COMPLETED )</brief_title>
	<detailed_description>Study drug administer accord random select sequence schedule 2 constraint : Subjects receive consecutive dos formulation , formulation give morning even course 3-day treatment period .</detailed_description>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Asenapine</mesh_term>
	<criteria>least 18 year age legal minimum age trial participation ; male , female childbearing potential free acute exacerbation psychosis least 3 month ; current DSMIV diagnosis schizophrenia ( paranoid , disorganize , catatonic , undifferentiated subtype ) , schizoaffective disorder ; delusional disorder , major depressive disorder , bipolar disorder , chronic antipsychotic therapy indicate ; correctly identify 3 4 basic flavor ( bitter , sweet , salty , sour ) neutral taste paradigm ; receive oral antipsychotic medication . uncontrolled , unstable clinically significant medical condition clinically significant abnormal laboratory , vital sign , PE , ECGs find Screening ; previously experience NMRB ( also know vasovagal reflex ) sensitivity fainting ; positive serum pregnancy test screening , intention become pregnant within next 30 day ; history seizure ; history neuromalignant syndrome ; current ( past 6 month ) substance abuse dependence accord DSMIVTR criterion ( exclude nicotine ) ; imminent risk selfharm harm others ; currently receive depot antipsychotic , fluphenazine decanoate , haloperidol decanoate , Risperdal Consta , within least 1 dose cycle Day5 ; impairment taste functioning ; receive lithium topiramate ; judge principal investigator ( PI ) unable reliably respond questionnaire base clinically significant cognitive impairment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>